HKD 2.49
(1.63%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -194.36 Million CNY | 18.16% |
2022 | -237.5 Million CNY | 45.48% |
2021 | -435.62 Million CNY | -19.09% |
2020 | -365.78 Million CNY | -1260.04% |
2019 | -26.89 Million HKD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -13.99 Million HKD | 71.07% |
2024 Q2 | -13.87 Million HKD | 0.15% |
2023 Q2 | -46.53 Million HKD | 5.52% |
2023 FY | -194.36 Million CNY | 18.16% |
2023 Q4 | -49.34 Million HKD | -2.57% |
2023 Q3 | -48.1 Million HKD | -3.37% |
2023 Q1 | -49.25 Million HKD | 15.32% |
2022 Q2 | -122.49 Million HKD | 0.0% |
2022 FY | -237.5 Million CNY | 45.48% |
2022 Q4 | -58.16 Million HKD | -2.58% |
2022 Q3 | -56.7 Million HKD | 53.7% |
2021 Q4 | -195.66 Million HKD | 0.0% |
2021 Q2 | -239.73 Million HKD | 0.0% |
2021 FY | -435.62 Million CNY | -19.09% |
2020 FY | -365.78 Million CNY | -1260.04% |
2019 FY | -26.89 Million HKD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Uni-Bio Science Group Limited | 70.87 Million HKD | 374.227% |
CK Life Sciences Int'l., (Holdings) Inc. | 17.25 Million HKD | 1226.733% |